[HTML][HTML] Efficacy of pneumococcal polysaccharide vaccine

RM Andrews, SA Moberley - CMAJ, 2009 - Can Med Assoc
2008;(1): CD000422. 4. Guyatt GH, Oxman AD, Vist GE, et al.; GRADE Working Group.
GRADE: an emerging consensus on rating quality of evidence and strength of …

Polysaccharide pneumococcal vaccines: Existing guidance is at variance with the evidence

T Jefferson, V Demicheli - BMJ, 2002 - bmj.com
Infection with Streptococcus pneumoniae (pneumo-coccus) is a leading cause of illness in
young children and of illness and death in elderly people and people with immune …

Polysaccharide based vaccines for the prevention of pneumococcal infections

M Moreau, D Schulz - 2000 - Taylor & Francis
1. INTRODUCTION Streptococcus pneumoniae remains an important cause of infections in
this end of the 20th century and is responsible for invasive diseases-pneumonia, meningitis …

[HTML][HTML] Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials

RA Moore, PJ Wiffen, BA Lipsky - BMC Family Practice, 2000 - Springer
The objective was to review the evidence of effectiveness of the polyvalent polysaccharide
pneumococcal vaccine from prospective properly randomised controlled trials comparing …

Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults

L Watson, BJ Wilson, N Waugh - Vaccine, 2002 - Elsevier
Pneumococcal polysaccharide vaccine is recommended in western countries for individuals
at high risk of pneumococcal illness. We undertook a systematic review of randomised …

[CITATION][C] Vaccine against pneumococcal pneumonia in Adults.

AW Swartz - The New England journal of medicine, 2015 - europepmc.org
A comment on this article appears in" Vaccine against Pneumococcal Pneumonia in Adults."
N Engl J Med. 2015 Jul 2; 373 (1): 93. This is a comment on" Polysaccharide conjugate …

Updated recommendations for the use of pneumococcal polysaccharide vaccine

EJ Miazga, AN Biesboer, MS Hayney - Journal of the American …, 2010 - japha.org
Streptococcus pneumoniae, or pneumococcus, and its associated infections are leading
causes of serious illness throughout the world. Infections originating from this species of …

Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations

GAW Bruyn, R Van Furth - European Journal of Clinical Microbiology and …, 1991 - Springer
Streptococcus pneumoniae is the primary cause of community-acquired pneumonia,
meningitis in adults and otitis media in infants and children and the third cause of meningitis …

[PDF][PDF] 23-valent pneumococcal polysaccharide vaccine: WHO position paper

World Health Organization - Weekly Epidemiological Record …, 2008 - apps.who.int
In accordance with its mandate to provide guidance to Member States on health-pol icy
matters, WHO issues a series of regu larly updated position papers on vaccines and vaccine …

Pneumococcal vaccination: Identifying barriers and strategies to improve administration rates

M Turner, C Parks, F Murphy, L Dick… - AAACN …, 2014 - search.proquest.com
Abstract The Immunization Action Coalition (Atkinson & Kroger, 2011) recognizes the
following" at risk" populations for which the pneumococcal polysaccharide vaccine (PPSV) is …